{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:46:40Z","timestamp":1767134800903,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":62,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004568.pub2","type":"reference-entry","created":{"date-parts":[[2005,7,4]],"date-time":"2005-07-04T13:18:45Z","timestamp":1120483125000},"source":"Crossref","is-referenced-by-count":5,"title":["Combination injectable contraceptives for contraception"],"prefix":"10.1002","author":[{"given":"Maria F","family":"Gallo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laureen M","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth F","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"d'Arcangues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,7,20]]},"reference":[{"key":"10.1002\/14651858.CD004568.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0010-7824(96)00173-4","article-title":"Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and Cyclofem, in Vietnamese women","volume":"54","author":"Cuong","year":"1996","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0010-7824(94)90005-1","article-title":"Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt","volume":"49","author":"Hassan","year":"1994","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0010-7824(99)00064-5","article-title":"Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects","volume":"60","author":"Hassan","year":"1999","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0010-7824(95)00012-Y","article-title":"Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research","volume":"51","author":"Datey","year":"1995","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0010-7824(90)90101-Z","article-title":"A multicentre phase III comparative study of two hormonal contraceptive preparations NET-OEN (50 mg) + E2 valerate (5 mg) given every month and NET-OEN (200 mg) given every 2 months as intramuscular injection--a report of 12-month study","volume":"42","year":"1990","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB6|cit6","first-page":"41","article-title":"Clinical evaluation of two once-a-month injectable contraceptives; Cyclofem and Mesigyna","volume":"18","author":"Mostafa","year":"1994","journal-title":"Assiut Medical Journal"},{"key":"10.1002\/14651858.CD004568.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0010-7824(97)00203-5","article-title":"Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea","volume":"57","author":"Piya-Anant","year":"1998","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0010-7824(86)90046-6","article-title":"Pharmacodynamic assessment of dihydroxyprogesterone acetophenide plus estradiol enanthate as a monthly injectable contraceptive","volume":"33","author":"Recio","year":"1986","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.contraception.2005.04.001","article-title":"Comparative acceptability of combined and progestin-only injectable contraceptives in Kenya","volume":"72","author":"Ruminjo","year":"2005","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0010-7824(95)00013-Z","article-title":"A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. I. Contraceptive efficacy and side effects","volume":"51","author":"Sang","year":"1995","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0010-7824(95)00014-2","article-title":"A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns","volume":"51","author":"Sang","year":"1995","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1783\/147118907782101887","article-title":"A comparative study of Cyclofem\u00ae and depot medroxyprogesterone acetate (DMPA) effects on endometrial vasculature","volume":"33","author":"Simbar","year":"2007","journal-title":"Journal of Family Planning and Reproductive Health Care"},{"key":"10.1002\/14651858.CD004568.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0010-7824(00)00110-4","article-title":"Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns","volume":"61","author":"Kesseru","year":"2000","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB14|cit14","first-page":"45","article-title":"Efficiency of two injectable contraceptives (cycloprovera and HRP-102) monthly administered by intramuscular via","volume":"15","author":"G\u00f3mez Alzugaray","year":"1989","journal-title":"Revista Cubana de Obstetricia y Ginecolog\u00eda"},{"key":"10.1002\/14651858.CD004568.pub2-BIB15|cit15","first-page":"98","article-title":"Comparative evaluation of two once-a-month contraceptive injections","volume":"39","author":"Kazi","year":"1989","journal-title":"Journal of the Pakistan Medical Association"},{"key":"10.1002\/14651858.CD004568.pub2-BIB16|cit16","first-page":"53","article-title":"Comparative study of 2 injectable contraceptives administered in monthly doses: cycloprovera and HRP-102","volume":"19","author":"Lang Prieto","year":"1993","journal-title":"Revista Cubana de Obstetricia y Ginecolog\u00eda"},{"key":"10.1002\/14651858.CD004568.pub2-BIB17|cit17","first-page":"264","article-title":"Efficacy, acceptability and side-effects of two once-a-month injectable contraceptives [Abstract]","volume":"6","author":"Santoso","year":"1990","journal-title":"Advances in Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB19|cit18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(88)90144-8","article-title":"A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: I. Contraceptive efficacy and side effects","volume":"37","year":"1988","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB18|cit19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0010-7824(89)90126-1","article-title":"A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection. II. The comparison of bleeding patterns","volume":"40","year":"1989","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0010-7824(97)00139-X","article-title":"Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism","volume":"56","year":"1997","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0010-7824(98)00003-1","article-title":"Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna\u00ae and Cyclofem\u00ae) on glucose metabolism and liver function","volume":"57","year":"1998","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0010-7824(85)90081-2","article-title":"Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations","volume":"31","author":"Aedo","year":"1985","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB23|cit23","first-page":"27","article-title":"Acceptability study of the two versus three monthly injectable contraceptives","volume":"11","author":"Aly","year":"1984","journal-title":"Population Studies"},{"key":"10.1002\/14651858.CD004568.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0010-7824(95)00080-T","article-title":"A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives","volume":"51","author":"Bassol","year":"1995","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0010-7824(85)90042-3","article-title":"Indian Council of Medical Research. Task Force on Hormonal Contraception. Phase II randomized clinical trial with norethisterone oenanthate 50 mg alone and in combination with 5 mg or 2.5 mg of either estradiol valerate or cypionate as a monthly injectable contraceptive","volume":"32","author":"Baweja","year":"1985","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02436100","article-title":"Carbohydrate metabolism comparative study with the new injectable mesigyna and a three-phasic oral contraceptive [Abstract]","volume":"11","author":"Benagiano","year":"1995","journal-title":"Advances in Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0010-7824(97)00033-4","article-title":"Comparative clinical evaluation of the effect on carbohydrate and lipid metabolism of two norethisterone-containing hormonal contraceptives: Mesigyna and TriNovum","volume":"55","author":"Benagiano","year":"1997","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB28|cit28","first-page":"11","article-title":"Controlled trial with a monthly combination injectable contraceptive in Europe","volume":"15","author":"Brucker","year":"2001","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD004568.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0010-7824(97)00018-8","article-title":"Multicenter, double-blind, comparative clinical study on the efficacy and acceptability of a monthly injectable contraceptive combination of 150 mg dihydroxyprogesterone acetophenide and 10 mg estradiol enanthate compared to a monthly injectable contraceptive combination of 90 mg dihydroxyprogesterone acetophenide and 6 mg estradiol enanthate","volume":"55","author":"Coutinho","year":"1997","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.contraception.2005.08.016","article-title":"Comparison of two regimens of a monthly injectable contraceptive containing dihydroxyprogesterone acetophenide and estradiol enanthate","volume":"73","author":"Coutinho","year":"2006","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0010-7824(72)90031-5","article-title":"Control of fertility by monthly injections of a mixture of norgestrel and a long-acting estrogen. A preliminary report","volume":"5","author":"Souza","year":"1972","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0010-7824(87)90093-X","article-title":"A multicentered pharmacokinetic, pharmacodynamic study of once-a-month injectable contraceptives. I. Different doses of HRP112 and of DepoProvera. World Health Organization Task Force on Long-acting Systemic Agents for Fertility Regulation","volume":"36","author":"Garza-Flores","year":"1987","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0010-7824(89)90037-1","article-title":"Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters","volume":"39","author":"Haiba","year":"1989","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0010-7824(00)00098-6","article-title":"Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive","volume":"61","author":"Jain","year":"2000","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/0002-9378(71)90268-7","article-title":"Conception control by cyclic injections of norethisterone enanthate and estradiol unducelate","volume":"110","author":"Karim","year":"1971","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004568.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-3-642-73790-9_20","article-title":"Monthly injectable contraception with norethisterone enanthate plus estradiol valerate","volume-title":"Female contraception: update and trends","author":"Kesseru","year":"1988"},{"key":"10.1002\/14651858.CD004568.pub2-BIB37|cit37","first-page":"269","article-title":"Monthly injectable contraceptives: are they a valuable addition to the birth control cafeteria [abstract]","volume":"101","author":"Khalaf","year":"1994","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004568.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0010-7824(90)90052-W","article-title":"Hemostatic changes in women using a monthly injectable contraceptive for one year","volume":"42","author":"Meng","year":"1990","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB39|cit39","first-page":"33","article-title":"Changes in serum lipids, lipoproteins and apolipoproteins during the use of two once-a-month injectable contraceptives; Cyclofem and Mesigyna","volume":"18","author":"Mostafa","year":"1994","journal-title":"Assiut Medical Journal"},{"key":"10.1002\/14651858.CD004568.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0010-7824(93)90096-P","article-title":"Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives","volume":"47","author":"Oyelola","year":"1993","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0010-7824(01)00243-8","article-title":"Delayed first injection of the once-a-month injectable contraceptive containing 25 mg medroxyprogesterone acetate and 5 mg estradiol-cypionate: effects on cervical mucus","volume":"64","author":"Petta","year":"2001","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0015-0282(01)01672-7","article-title":"Delayed first injection of the once-a-month injectable contraceptive containing 25 mg of medroxyprogesterone acetate and 5 mg of E(2)-cypionate: effects on ovarian function","volume":"75","author":"Petta","year":"2001","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD004568.pub2-BIB43|cit43","first-page":"15","article-title":"Controlled trial with a monthly combination injectable contraceptive in the USA","volume":"15","author":"Shulman","year":"2001","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD004568.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0010-7824(80)90008-6","article-title":"The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women","volume":"21","author":"Werawatgoompa","year":"1980","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0010-7824(03)00164-1","article-title":"Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1\/35) on coagulation and fibrinolysis","volume":"68","year":"2003","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0010-7824(97)00034-6","article-title":"Return of fertility after discontinuation of the once-a-month injectable contraceptive Cyclofem","volume":"55","author":"Bahamondes","year":"1997","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0010-7824(97)00162-5","article-title":"Self-administration with Uniject of the once-a-month injectable contraceptive Cyclofem","volume":"56","author":"Bahamondes","year":"1997","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0010-7824(94)90003-5","article-title":"Review of ovulation return upon discontinuation of once-a-month injectable contraceptives","volume":"49","author":"Bassol","year":"1994","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(86)90006-5","article-title":"The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction","volume":"34","author":"Belsey","year":"1986","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(02)00474-2","article-title":"Amenorrhea associated with contraception-an international study on acceptability","volume":"67","author":"Glasier","year":"2003","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB51|cit51","first-page":"157","article-title":"Injectable contraceptives","volume-title":"Contraceptive Technology","author":"Goldberg","year":"2007"},{"key":"10.1002\/14651858.CD004568.pub2-BIB52|cit52","unstructured":"IPPF Directory of Hormonal Contraceptives Available at http:\/\/contraceptive.ippf.org."},{"key":"10.1002\/14651858.CD004568.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0889-8545(05)70171-6","article-title":"Injectable contraception. New and existing options","volume":"27","author":"Kaunitz","year":"2000","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"key":"10.1002\/14651858.CD004568.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s004040100174","article-title":"Lunelle monthly injectable contraceptive. An effective, safe, and convenient new birth control option","volume":"265","author":"Kaunitz","year":"2001","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD004568.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0010-7824(94)90034-5","article-title":"Once-a-month injectable contraceptives: efficacy and reasons for discontinuation","volume":"49","author":"Koetsawang","year":"1994","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1331\/JAPhA.2007.06112","article-title":"Pharmacy and clinic partnerships to expand access to injectable contraception","volume":"47","author":"Monastersky Maderas","year":"2007","journal-title":"Journal of the American Pharmacists Association (2003)"},{"key":"10.1002\/14651858.CD004568.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01443619409027641","article-title":"A review of \"once-a-month\" combined injectable contraceptives","volume":"14 Suppl (1)","author":"Newton","year":"1994","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004568.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(80)92765-8","article-title":"Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand","volume":"1","author":"Pardthaisong","year":"1980","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004568.pub2-BIB59|cit59","unstructured":"Pharmacy Access Partnership Injectable Contraceptive (IC) Program www.pharmacyaccess.org\/ICProgram.htm"},{"key":"10.1002\/14651858.CD004568.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ije\/31.1.150","article-title":"Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed","volume":"31","author":"Robinson","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004568.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0010-7824(74)90073-0","article-title":"The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review","volume":"10","author":"Schwallie","year":"1974","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD004568.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2471\/BLT.07.040162","article-title":"Contraceptive injections by community health workers in Uganda: a nonrandomized community trial","volume":"85","author":"Stanback","year":"2007","journal-title":"Bulletin of the World Health Organization"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004568.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2008,10,8]],"date-time":"2008-10-08T00:00:00Z","timestamp":1223424000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004568.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:36:58Z","timestamp":1628530618000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004568.pub2"}},"subtitle":[],"editor":[{"given":"David A","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2005,7,20]]},"references-count":62,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004568.pub2","relation":{},"subject":[],"published":{"date-parts":[[2005,7,20]]}}}